Dr Agarwal Healthcare IPO allotment status : The Dr Agarwal Healthcare IPO share allotment will be finalised on Monday, February 3. Investors who applied for the Dr Agarwals IPO can check the Dr ...
Dr Agarwal's Health initial public offering (IPO), which closed for bidding on January 31, witnessed a decent response from investors across all segments. All eyes are now on allotment of Dr ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Rates of SIDS saw a precipitous decline in the 1990s due to a national information campaign about the safest way for babies ...
Four top companies caught our eye, and when they are among the top stock picks at the world’s most prestigious investment bank, they likely will also catch the eye of savvy investors.
Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is ...
Quant offers tools that simplify stock picking by analyzing financial data to highlight stocks with the strongest investment fundamentals. Alpha Picks offers a more efficient approach to smarter ...
1219.95. On previous day, the Dr. Reddys Share Price (NSE) closed at Rs. 1204.95, featuring among the most traded securities on the National Stock Exchange.
Dr Reddys Labs Consolidated December 2024 Net Sales at Rs 8,381.20 crore, up 15.81% Y-o-Y Jan 28 2025 01:32 PM Hold Dr Reddys Laboratories; target of Rs 1245: KR Choksey Jan 27 2025 12:36 PM ...
Shares of ClouDr Group rose sharply in Hong Kong after the Chinese medical software provider said it will integrate AI firm DeepSeek's model into its core product. The stock rose 12% to HK$1.81 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback